Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Supernus Pharmaceuticals (S49.F) Q2 2024 Earnings
S49.F
8
May
Confirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-0.27
-0.01
0.25
0.52
Details
Expected EPS
0.24420375000000002
Actual EPS
0
Surprise EPS
-0.24
Surprise Percent
+100%
Description
Supernus Pharmaceuticals (S49.F) will report earnings of for Q2 2024 on May 08, 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login